The Presidential Debate On Wikipedia

Donald Trump will officially become the 45th president of the United States when he is inaugurated on January 20th of 2017. At this time all of the social media accounts belonging to the president will be transitioned to him. When it comes to Wikipedia this becomes a bit more complicated. Although Wikipedia is an encyclopedia sourced for crowds it appears the users can’t decide when the official office will be taken over by Donald Trump. Even though anyone is capable of editing the pages the inaugural date must be decided first.

In just one morning the Wikipedia page has changed no less than eight times. Some believe that since Barack Obama only remains in the office as president until January 20th of 2017 the page needs updating. Others believe that until noon on that day the president is still Barack Obama. Since the page is protected only specific editors are allowed to make any changes. At this point the editors may be envisioning the days of print encyclopedia. At that point in time there would not have been an issue. As of 12:01 P.M. om January 20th of 2017 the page shows that Donald Trump is now the official president of the United States.

Wikipedia is an amazing source for any business who is interested in managing their reputation online. Get your Wiki means there are editing services available at Wikipedia who take all of the hassles out of creating your own page. This gives you a professional advantage and opportunities regarding your personal or business online presence. You are able to brand or edit your business. Your Wikipedia page can actually improve your reputation or that of your business. You are adding credibility, prestige and authenticity to your brand and your business. You are gaining a presence on a highly credible website that showcases your business with dignity. This can result in an increase in your sales and heighten your visibility with the search engines. Due to the prime spots held by Google’s search pages your business gets an SEO boost at no cost. Wikipedia can improve your businesses reputation so there will never be a better time to Get Your Wiki.

JeanMarie Guenot Extraordinary Business Woman and Scientist

 

LinkedIn makes it clear that JeanMarie Guenot has over 20 years’ experience in the biotechnology and pharmaceutical industry. Her history has her working in public and private companies, in pharmaceutical R&D, she has a vast amount of experience in commercial development, project and alliance management, business development and venture capital.

 

She was a business advisor in Basel, Switzerland and Shanghai, China for Hoffmann-La Roche from 2008 to 2009, Before this she served as the Vice President of Corporate and Business Development for PDL’s BioPharma. In this position, she led mergers and acquisitions, licensing, and alliance management for PDL’s R&D and in commercial product portfolios.

 

Dr. Guenot negotiated an $800 million 50:50 co-development and commercialization collaboration that involved three 2 Phase autoimmune and cancer disease drug candidates. This transaction also included a $100 million equity investment in PDL. In 2005 she received the BioBusiness Network’s innovative Bio-Partnering Award, and in 2006 was awarded the Deal of Distinction from the Licensing Executives Society.

 

JeanMarie Guenot started her career managing venture capital investments at Atlas Venture.  When she started her scientific career, it was as a principal scientist in preclinical R&D at Hoffman-La Roche where she developed drugs for metabolic diseases, autoimmune diseases, inflammation, and oncology. Her training is in physical and medicinal chemistry, focusing on quantum mechanical and methods for molecular dynamics, X-ray and NMR refinement and drug design.

 

Dr. Gueout graduated from the University of California, San Francisco where she received her Ph.D. and her MBA from the University of Pennsylvania, The Wharton School.  All of which is covered on her website JeanmarieGuenot.com.

 

She is at present the President of Amphivena Therapeutics, where they are working to find treatment and therapies for hematological conditions and malignancies. Amphivena Therapeutics, Inc. is a developer of cancer immunotherapeutics. Under an agreement with Janssen Biotech they have selected a clinical candidate against a tumor antigen and will further development in hematologic malignancies.

 

JeanMarie Guenot’s experience has made her into a dynamic business woman who has a well-disciplined mind and can and does apply all that she has learned to help ease suffering and try to make the world a better place for everyone to live in.  Jeanmarie has just negotiated a major partnership with Takeda, which you can read about on their website: https://www.takeda.com/news/2017/20170111_7659.html